CRS
4
0
1
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by 1 Frontosphenoethmoidektomie 2 Draf 2b 3 Draf 3
Research Leaders
6 sponsors active, led by The Technion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (4)
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis (EDSPD Protocol)
Subjective and Objective Outcome of ESS in CRSwNP
The Role of Budesonide Intrapolyp Injection in CRSwNP
Applications of Nanotechnology and Chemical Sensors for the Detection and Identification of Chronic Sinusitis Subtypes by Respiratory Samples
Research Network
Common Treatments
- 1 Frontosphenoethmoidektomie 2 Draf 2b 3 Draf 31
- Edspd1
- Budesonide Nasal Wash1
- Budesonide Intrapolyp Injection1
- Prednisolone1
Active Sponsors
- The Technion1
- National Heart, Lung, and Blood Institute (NHLBI)1
- Hillel Yaffe Medical Center1
- University of Zurich1
- University of Alabama at Birmingham1
Top Investigators
University of Alabama at Birmingham
Related Conditions
- Polyp Nasal1